1. Home
  2. GPCR vs NEOG Comparison

GPCR vs NEOG Comparison

Compare GPCR & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • NEOG
  • Stock Information
  • Founded
  • GPCR 2016
  • NEOG 1981
  • Country
  • GPCR United States
  • NEOG United States
  • Employees
  • GPCR N/A
  • NEOG N/A
  • Industry
  • GPCR
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • GPCR
  • NEOG Health Care
  • Exchange
  • GPCR Nasdaq
  • NEOG Nasdaq
  • Market Cap
  • GPCR 1.1B
  • NEOG 1.0B
  • IPO Year
  • GPCR 2023
  • NEOG 1989
  • Fundamental
  • Price
  • GPCR $19.01
  • NEOG $5.44
  • Analyst Decision
  • GPCR Strong Buy
  • NEOG Buy
  • Analyst Count
  • GPCR 7
  • NEOG 2
  • Target Price
  • GPCR $76.17
  • NEOG $7.50
  • AVG Volume (30 Days)
  • GPCR 684.5K
  • NEOG 6.7M
  • Earning Date
  • GPCR 08-07-2025
  • NEOG 07-29-2025
  • Dividend Yield
  • GPCR N/A
  • NEOG N/A
  • EPS Growth
  • GPCR N/A
  • NEOG N/A
  • EPS
  • GPCR N/A
  • NEOG N/A
  • Revenue
  • GPCR N/A
  • NEOG $905,996,000.00
  • Revenue This Year
  • GPCR N/A
  • NEOG N/A
  • Revenue Next Year
  • GPCR N/A
  • NEOG $0.48
  • P/E Ratio
  • GPCR N/A
  • NEOG N/A
  • Revenue Growth
  • GPCR N/A
  • NEOG N/A
  • 52 Week Low
  • GPCR $13.22
  • NEOG $3.87
  • 52 Week High
  • GPCR $47.48
  • NEOG $18.58
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 33.96
  • NEOG 51.89
  • Support Level
  • GPCR $18.50
  • NEOG $4.94
  • Resistance Level
  • GPCR $19.40
  • NEOG $5.74
  • Average True Range (ATR)
  • GPCR 1.18
  • NEOG 0.28
  • MACD
  • GPCR -0.17
  • NEOG 0.10
  • Stochastic Oscillator
  • GPCR 9.86
  • NEOG 73.04

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Share on Social Networks: